Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial von Hochhaus, A, Saglio, G, Hughes, T P, Larson, R A, Kim, D-W, Issaragrisil, S, le Coutre, P D, Etienne, G, Dorlhiac-Llacer, P E, Clark, R E, Flinn, I W, Nakamae, H, Donohue, B, Deng, W, Dalal, D, Menssen, H D, Kantarjian, H M

Volltext

Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results von Hughes, T P, Leber, B, Cervantes, F, Spector, N, Pasquini, R, Clementino, N C D, Schwarer, A P, Dorlhiac-Llacer, P E, Mahon, F-X, Rea, D, Guerci-Bresler, A, Kamel-Reid, S, Bendit, I, Acharya, S, Glynos, T, Dalal, D, Branford, S, Lipton, J H

Volltext

PB2028: TREATING MULTIPLE MYELOMA IN A RESOURCE‐LIMITED SETTING: REAL‐WORLD OUTCOMES von Martinez, G., Seguro, F., Jacomassi, M., Visnadi, H., Atanazio, M., Szor, R., Neffá, P., Pereira, T., Silva, W., Dorlhiac‐Llacer, P., Velasques, R., Bassolli, L., Rocha, V.

Volltext

Design and baseline characteristics of SALT‐HF trial: hypertonic saline therapy in ambulatory heart failure von Cobo Marcos, M., Comín‐Colet, J., Espriella, R., Rubio Gracia, J., Morales‐Rull, J. L., Zegrí, I., Llacer, P., Diez‐Villanueva, P., Jiménez‐Marrero, S., Juan Bagudá, J., Ortiz Cortés, C., Goirigolzarri‐Artaza, J., García‐Pinilla, J. M., Barrios, E., Prado Díaz, S., Montero Hernández, E., Sanchez‐Marteles, M., Nuñez, J.

Volltext

Role of radiotherapy for sarcomas von Ducassou, A., Llacer, C., Sargos, P., Moureau-Zabotto, L., Sunyach, M-P, Thariat, J., Le Pechoux, C.

Volltext

Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia von Azevedo, M C, Velloso, E D R P, Buccheri, V, Chamone, D A F, Dorlhiac-Llacer, P E

Volltext

O-143 Characterization of vaginal and endometrial microbiome in patients with chronic endometritis (CE) von LOZANO, P, Bernabeu, A, Lledó, B, Morales, R, Aranda, F I, Llacer, J, Bernabeu, R

Volltext

Place de la radiothérapie dans la prise en charge des sarcomes von Ducassou, A., Llacer, C., Sargos, P., Moureau-Zabotto, L., Sunyach, M.-P., Thariat, J., Le Péchoux, C.

Volltext

Evaluation of chromosomal abnormalities by cIg-FISH and association with proliferative and apoptotic indexes in multiple myeloma von Linardi, C C G, Martinez, G, Velloso, E D R P, Leal, A M, Kumeda, C A, Buccheri, V, Azevedo, R S, Peliçario, L M, Dorlhiac-Llacer, P

Volltext

Clinical characteristics and risk factors for mortality on admission in patients with heart failure hospitalized due to COVID-19 in Spain von Llàcer Iborra, P, Núñez Villota, J

Volltext

Evaluation of chromosomal abnormalities by clg-FISH and association with proliferative and apoptotic indexes in multiple myeloma von Linardi, CCG, Martinez, G, Velloso, EDRP, Leal, A M, Kumeda, CA, Buccheri, V, Azevedo, R S, Pelicario, L M, Dorlhiac-Llacer, P

Volltext

Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation von Conchon, M, Sanabani, S S, Bendit, I, Serpa, M, Filho, U A, de Barros Ferreira, P, Novaes, M M Y, Saboya, R, Llacer-Dorliac, P E, Dulley, F L

Volltext

Potent, transient inhibition of BCR-ABL with dasatinib 100 mg daily achieves rapid and durable cytogenetic responses and high transformation-free survival rates in chronic phase ch... von SHAH, Neil P, KIM, Dong-Wook, LAMBERT, Alexandre, MATLOUB, Yousif, HOCHHAUS, Andreas, KANTARJIAN, Hagop, ROUSSELOT, Philippe, DORLHIAC LLACER, Pedro Enrique, ENRICH, Alicia, VELA-OJEDA, Jorge, SILVER, Richard T, KHOURY, Hanna Jean, MÜLLER, Martin C

Volltext

Comparison of conventional tube test with diamed gel microcolumn assay for anti-D titration von Novaretti, M. C. Z., Jens, E., Pagliarini, T., Bonifácio, S. L., Dorlhiac-Llacer, P. E., Chamone, D. A. F.

Volltext

Differential characteristics of acute heart failure in very elderly patients: the prospective RICA study von Huerta-Preciado, Jorge, Franco, Jonathan, Formiga, Francesc, Iborra, Pau Llácer, Epelde, Francisco, Franco, Álvaro González, Ormaechea, Gabriela, Manzano, Luis, Cepeda-Rodrigo, José María, Montero-Pérez-Barquero, Manuel

Volltext

Immunohematological Findings in Myelodysplastic Syndrome von Novaretti, M.C.Z., Sopelete, C.R., Velloso, E.R.P., Rosa, M.F.C., Dorlhiac-Llacer, P.E., Chamone, D.A.F.

Volltext

Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib von Hughes, Timothy P., Lipton, Jeffrey H., Spector, Nelson, Cervantes, Francisco, Pasquini, Ricardo, Clementino, Nelma Cristina D., Dorlhiac Llacer, Pedro Enrique, Schwarer, Anthony P., Mahon, Francois-Xavier, Rea, Delphine, Branford, Susan, Purkayastha, Das, Collins, LaTonya, Szczudlo, Tomasz, Leber, Brian

Volltext

Comparison of conventional tube test technique and gel microcolumn assay for direct antiglobulin test: A large study von Novaretti, M.C.Z., Jens, E., Pagliarini, T., Bonifacio, S.L., Dorlhiac-Llacer, P.E., Chamone, D.A.F.

Volltext

Reduction in hospitalisations and emergency department visits for frail patients with heart failure: Results of the UMIPIC healthcare programme von Cerqueiro, J M, González-Franco, A, Montero-Pérez-Barquero, M, Llácer, P, Conde, A, Dávila, M F, Carrera, M, Serrado, A, Suárez, I, Pérez-Silvestre, J, Satué, J A, Arévalo-Lorido, J C, Rodríguez, A, Herrero, A, Jordana, R, Manzano, L

Volltext

ABO genotyping in leukemia patients reveals new ABO variant alleles von Novaretti, M C Z, Domingues, A E, Manhani, R, Pinto, E M, Dorlhiac-Llacer, P E, Chamone, D A F

Volltext